Evidence-based recommendations for antiviral prophylaxis in allogeneic... | Download Scientific Diagram
Acyclovir Given As Prophylaxis Against Oral Ulcers In Acute Myeloid Leukaemia: Randomised, Double Blind, Placebo Controlled Tria
Valacyclovir dosage regimens corresponding to intravenous and oral... | Download Scientific Diagram
PDF] Low-Dose Acyclovir Prophylaxis for Varicella zoster Reactivation in Autologous Hematopoietic Cell Transplantation Recipients | Semantic Scholar
Key Cornea Trials: The Legacy of HEDS, the Promise of ZEDS - American Academy of Ophthalmology
25. HERPES SIMPLEX AND ZOSTER
Antiviral prophylaxis for preventing herpes zoster in hematopoietic stem cell transplant recipients: A systematic review and meta‐analysis | Semantic Scholar
Prevention of herpes zoster reactivation in patients receiving proteasome inhibitors | Research To Practice
Varicella-Zoster Virus Infection in Children and Adolescents
Acyclovir Prophylaxis of Herpes-Simplex-Virus Infections — A Randomized, Double-Blind, Controlled Trial in Bone-Marrow-Transplant Recipients | NEJM
Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial - The Lancet
2020–2021 BCSC Basic and Clinical Science Course™
A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT | Bone Marrow Transplantation
Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation - ScienceDirect
A Risk-Benefit Evaluation of Aciclovir for the Treatment and Prophylaxis of Herpes Simplex Virus Infections | SpringerLink
Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation | SpringerLink